Mucormycosis is a devastating disease with a high mortality rate, typically affecting immunosuppressed individuals. Postoperative surgical site infections due to mucromycosis are rare, with only a handful of cases reported in the literature. Here, we describe a fatal case of post operative abdominal wound infection caused by mucormycosis in an immunocompetent man in his 70 s, who developed the infection following a laparotomy for bowel perforation. Initially, the growth of fungal species from a superficial wound swab was not considered significant until the patient exhibited signs of worsening sepsis. Limited operative debridement was performed for prognostication, in accordance with the family’s wishes. There was evidence of extensive significant invasive fungal infection, marked by necrosis extending into the abdominal wall fat and muscle. The patient was then transitioned to comfort measures and subsequently died. This case emphasizes the importance of maintaining a high level of clinical suspicion for mucormycosis, even in patients with minimal risk factors, and highlights the importance of prompt and aggressive treatment.
{"title":"Post operative abdominal wall mucormycosis infection after laparotomy for bowel perforation","authors":"Neha Kumta , Lawrence Huang , Gururaj Nagaraj , Lindsey Papacostas , Shradha Subedi","doi":"10.1016/j.idcr.2024.e01998","DOIUrl":"10.1016/j.idcr.2024.e01998","url":null,"abstract":"<div><p>Mucormycosis is a devastating disease with a high mortality rate, typically affecting immunosuppressed individuals. Postoperative surgical site infections due to mucromycosis are rare, with only a handful of cases reported in the literature. Here, we describe a fatal case of post operative abdominal wound infection caused by mucormycosis in an immunocompetent man in his 70 s, who developed the infection following a laparotomy for bowel perforation. Initially, the growth of fungal species from a superficial wound swab was not considered significant until the patient exhibited signs of worsening sepsis. Limited operative debridement was performed for prognostication, in accordance with the family’s wishes. There was evidence of extensive significant invasive fungal infection, marked by necrosis extending into the abdominal wall fat and muscle. The patient was then transitioned to comfort measures and subsequently died. This case emphasizes the importance of maintaining a high level of clinical suspicion for mucormycosis, even in patients with minimal risk factors, and highlights the importance of prompt and aggressive treatment.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"36 ","pages":"Article e01998"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221425092400074X/pdfft?md5=bbe4305f394eda5a124eb88c4a6d586c&pid=1-s2.0-S221425092400074X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141130359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 49-year-old female with multiple myeloma complicated by renal failure had dysuria. The urine culture revealed multidrug-resistant aeromonas caviae during her hospital stay. Her symptoms and signs significantly improved after receiving a seven-day course of piperacillin-tazobactam treatment. She had no history of urinary tract infections(UTIs). On follow-up, she felt clinically well. Aeromonas caviae is a rare cause of UTI. We review previous cases of aeromonas caviae UTIs. The purpose of this case report is to assist in the diagnosis and management of aeromonas caviae cystitis.
{"title":"Multidrug-resistant aeromonas caviae causing cystitis in a renal failure patient","authors":"Jiao Zhou , Tianbing Xiao , Yuqing Huang , Jianrong Tang , Xiaobing Zhang , Bei Jia , Jianguo Wu","doi":"10.1016/j.idcr.2024.e01999","DOIUrl":"10.1016/j.idcr.2024.e01999","url":null,"abstract":"<div><p>A 49-year-old female with multiple myeloma complicated by renal failure had dysuria. The urine culture revealed multidrug-resistant <em>aeromonas caviae</em> during her hospital stay. Her symptoms and signs significantly improved after receiving a seven-day course of piperacillin-tazobactam treatment. She had no history of urinary tract infections(UTIs). On follow-up, she felt clinically well. <em>Aeromonas caviae</em> is a rare cause of UTI. We review previous cases of <em>aeromonas caviae</em> UTIs. The purpose of this case report is to assist in the diagnosis and management of a<em>eromonas caviae</em> cystitis.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e01999"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000751/pdfft?md5=9669a6fe85732fae90331b46509afb7d&pid=1-s2.0-S2214250924000751-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141144057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scrofuloderma is most common presentation of cutaneous tuberculosis in India. A 15-years-old immunocompetent male presented with bilateral cervical necrotising lesions and was treated with ATTx9 months, without improvement. Patient was diagnosed with scrofuloderma and ZN staining revealed 2+acid-fast bacilli. Cartridge-based nucleic acid amplification test showed rifampicin resistance. Patient was initiated on shorter regimen, but deferred treatment owing to technical portal problems. After 3 months, neck swelling had enlarged and he was started on multi-drug regimen x24 months. This underlines requisite to consider scrofuloderma in differentials of bilateral cervical lesions and to periodically monitor compliance to prevent subsequent emergence of resistance.
{"title":"Bilateral scrofuloderma: An incessant entity","authors":"Parakriti Gupta , Ivneet Kour , Varsha Gupta , Varinder Saini , Lipika Singhal","doi":"10.1016/j.idcr.2024.e02097","DOIUrl":"10.1016/j.idcr.2024.e02097","url":null,"abstract":"<div><div>Scrofuloderma is most common presentation of cutaneous tuberculosis in India. A 15-years-old immunocompetent male presented with bilateral cervical necrotising lesions and was treated with ATTx9 months, without improvement. Patient was diagnosed with scrofuloderma and ZN staining revealed 2+acid-fast bacilli. Cartridge-based nucleic acid amplification test showed rifampicin resistance. Patient was initiated on shorter regimen, but deferred treatment owing to technical portal problems. After 3 months, neck swelling had enlarged and he was started on multi-drug regimen x24 months. This underlines requisite to consider scrofuloderma in differentials of bilateral cervical lesions and to periodically monitor compliance to prevent subsequent emergence of resistance.</div></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"38 ","pages":"Article e02097"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142652423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e01930
Jiafeng Zhang , Yaoting Liu , Hongkun Wu , Lin Zhou
Shigella typically causes gastrointestinal infections, and extra-intestinal manifestations are rare. We report the first known case of pyogenic cervical spondylitis co-infected with Escherichia coli and Shigella flexneri, highlighting the diagnostic challenges and clinical implications. A 53-year-old woman presented with neck pain for one month. MRI revealed C6 and C7 vertebrae abscesses. The patient underwent anterior cervical debridement and bone-graft fusion. Intraoperative pus culture grew Escherichia coli, while metagenomic next-generation sequencing detected both Escherichia coli and Shigella species. Intravenous imipenem 500 mg every 6 h was administered, leading to full wound healing at a 6-month follow-up. This case emphasizes the importance of considering Shigella infection in the differential diagnosis of pyogenic spondylitis and demonstrates the utility of a multi-pronged diagnostic approach.
{"title":"Is Shigella an under-recognized pathogen? A case of pyogenic cervical spondylitis caused by Escherichia coli and Shigella flexneri infection","authors":"Jiafeng Zhang , Yaoting Liu , Hongkun Wu , Lin Zhou","doi":"10.1016/j.idcr.2024.e01930","DOIUrl":"https://doi.org/10.1016/j.idcr.2024.e01930","url":null,"abstract":"<div><p><em>Shigella</em> typically causes gastrointestinal infections, and extra-intestinal manifestations are rare. We report the first known case of pyogenic cervical spondylitis co-infected with <em>Escherichia coli</em> and <em>Shigella flexneri</em>, highlighting the diagnostic challenges and clinical implications. A 53-year-old woman presented with neck pain for one month. MRI revealed C6 and C7 vertebrae abscesses. The patient underwent anterior cervical debridement and bone-graft fusion. Intraoperative pus culture grew <em>Escherichia coli</em>, while metagenomic next-generation sequencing detected both <em>Escherichia coli</em> and <em>Shigella</em> species. Intravenous imipenem 500 mg every 6 h was administered, leading to full wound healing at a 6-month follow-up. This case emphasizes the importance of considering <em>Shigella</em> infection in the differential diagnosis of pyogenic spondylitis and demonstrates the utility of a multi-pronged diagnostic approach.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"35 ","pages":"Article e01930"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000064/pdfft?md5=47c725f08544c11e6d5dc088853105cc&pid=1-s2.0-S2214250924000064-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e01966
Chuanchuan Liu , Hainin Fan
Alveolar echinococcosis (AE) is a common and significant public health problem caused by the larvae of the Echinococcus multilocularis. The occurrence of epididymal AE is rare and often overlooked in combination with mycobacterium tuberculosis infection. We report a case of a 34-year-old man who presented with right-sided scrotal enlargement with pain. Physical examination revealed an enlarged right scrotum with rupture. CT examination showed a blurred border and non-enhancing lesion on the right epididymis. Postoperative pathology and molecular biology identified an epididymal E. multilocularis infection. We report this rare case to emphasise the difficulty of preoperative diagnosis and the importance of complete surgical excision of the lesion.
{"title":"Epididymal alveolar echinococcosis and tuberculosis co-infection: A case report","authors":"Chuanchuan Liu , Hainin Fan","doi":"10.1016/j.idcr.2024.e01966","DOIUrl":"https://doi.org/10.1016/j.idcr.2024.e01966","url":null,"abstract":"<div><p>Alveolar echinococcosis (AE) is a common and significant public health problem caused by the larvae of the <em>Echinococcus multilocularis</em>. The occurrence of epididymal AE is rare and often overlooked in combination with mycobacterium tuberculosis infection. We report a case of a 34-year-old man who presented with right-sided scrotal enlargement with pain. Physical examination revealed an enlarged right scrotum with rupture. CT examination showed a blurred border and non-enhancing lesion on the right epididymis. Postoperative pathology and molecular biology identified an epididymal <em>E. multilocularis</em> infection. We report this rare case to emphasise the difficulty of preoperative diagnosis and the importance of complete surgical excision of the lesion.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"36 ","pages":"Article e01966"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000428/pdfft?md5=3397fe0fddeace7d11c53e33097aff05&pid=1-s2.0-S2214250924000428-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140607104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e01953
Qibin Liu , Xiaoman Zhou , Li Yao, Feng Xu, Penggang Tang, Ting Li, Di Yang, Fang Liu, Jian Sheng , Yuhui Jiang , Xiyong Dai , Xianxiang Chen
One patient with rifampin-resistant tuberculosis underwent emergency left pneumonectomy and thoracic gauze packing for hemoptysis due to recurrent hemoptysis after transcatheter arterial embolization. Vital signs were maintained by mechanical ventilation and medication. Tracheotomy and anti-tuberculosis treatment were performed. After half a year of follow-up, the patient's condition was stable.
{"title":"A case report of using gauze packing to treat postoperative chest bleeding after left pneumonectomy for secondary rifampicin-resistant tuberculosis","authors":"Qibin Liu , Xiaoman Zhou , Li Yao, Feng Xu, Penggang Tang, Ting Li, Di Yang, Fang Liu, Jian Sheng , Yuhui Jiang , Xiyong Dai , Xianxiang Chen","doi":"10.1016/j.idcr.2024.e01953","DOIUrl":"10.1016/j.idcr.2024.e01953","url":null,"abstract":"<div><p>One patient with rifampin-resistant tuberculosis underwent emergency left pneumonectomy and thoracic gauze packing for hemoptysis due to recurrent hemoptysis after transcatheter arterial embolization. Vital signs were maintained by mechanical ventilation and medication. Tracheotomy and anti-tuberculosis treatment were performed. After half a year of follow-up, the patient's condition was stable.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"36 ","pages":"Article e01953"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000295/pdfft?md5=cd5c9da1aac650fa5ba7ce5ad8816c96&pid=1-s2.0-S2214250924000295-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140764450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e01977
Priya Samuel , Andrew Brack , John C. Lam
Brodie’s abscess is a manifestation of subacute to chronic osteomyelitis, characterized as intraosseous abscess formation, usually on the metaphysis of the long tubular bones in the lower extremities of male pediatric patients. Clinically, Brodie’s abscess presents with atraumatic bone pain of an insidious onset, with absence of systemic findings. Delay in diagnosis is common, as diagnostic imaging, followed by biopsy for culture and histologic examination are generally required to secure a diagnosis of Brodie’s abscess. Treatment of Brodie’s abscess is non-standardized, and usually consists of surgical debridement and antibacterial therapy. Despite the variability in therapeutic approaches, outcomes of Brodie’s abscess treated with surgery and antibiotics are favourable. Herein we report a case of a delayed diagnosis of Brodie’s abscess in the upper extremity of an adult female. While she improved with treatment of Brodie’s abscess, the case serves to remind clinicians to consider this entity in adult individuals who present with atraumatic bone pain.
{"title":"An unusual case of Brodie’s abscess in the humerus of an adult female","authors":"Priya Samuel , Andrew Brack , John C. Lam","doi":"10.1016/j.idcr.2024.e01977","DOIUrl":"https://doi.org/10.1016/j.idcr.2024.e01977","url":null,"abstract":"<div><p>Brodie’s abscess is a manifestation of subacute to chronic osteomyelitis, characterized as intraosseous abscess formation, usually on the metaphysis of the long tubular bones in the lower extremities of male pediatric patients. Clinically, Brodie’s abscess presents with atraumatic bone pain of an insidious onset, with absence of systemic findings. Delay in diagnosis is common, as diagnostic imaging, followed by biopsy for culture and histologic examination are generally required to secure a diagnosis of Brodie’s abscess. Treatment of Brodie’s abscess is non-standardized, and usually consists of surgical debridement and antibacterial therapy. Despite the variability in therapeutic approaches, outcomes of Brodie’s abscess treated with surgery and antibiotics are favourable. Herein we report a case of a delayed diagnosis of Brodie’s abscess in the upper extremity of an adult female. While she improved with treatment of Brodie’s abscess, the case serves to remind clinicians to consider this entity in adult individuals who present with atraumatic bone pain.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"36 ","pages":"Article e01977"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000532/pdfft?md5=7685bd3d4b8eb379db6eee674dd2f53c&pid=1-s2.0-S2214250924000532-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140815147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02095
Hamza Inayat , Anna Branch , James J. Armstrong , Verena Juncal , Courtney Casserly
Purpose
This case report aims to emphasize the significance of the ocular manifestations in individuals with West Nile Virus (WNV) infection, with primary neurological involvement. By presenting a case of chorioretinal scarring secondary to WNV, we highlight the importance of a thorough ophthalmological evaluation in suspected cases of WNV to identify potential sight-threatening complications.
Observations
A 63-year-old woman presented with neurological symptoms following a trip to Denver, USA, including headaches, fever, and decreased consciousness. Despite initial treatment for suspected meningoencephalitis, her condition deteriorated, leading to focal seizures and profound weakness. Ophthalmological examination revealed chorioretinal lesions consistent with WNV retinopathy.
Conclusions
and Importance: WNV can present with neurological symptoms, and ocular complications can lead to significant visual impairment. This case report highlights the importance of asking individuals with suspected WNV about ocular symptoms. Despite the absence of a preventive treatment for ocular manifestations, clinicians must stay attentive to ocular symptoms in patients to mitigate potential complications, such as chorioretinal neovascularization, which can be treated with anti-vascular endothelial growth factor therapy injections.
{"title":"Insight into ocular complications of West Nile Virus: A case report of chorioretinal scarring","authors":"Hamza Inayat , Anna Branch , James J. Armstrong , Verena Juncal , Courtney Casserly","doi":"10.1016/j.idcr.2024.e02095","DOIUrl":"10.1016/j.idcr.2024.e02095","url":null,"abstract":"<div><h3>Purpose</h3><div>This case report aims to emphasize the significance of the ocular manifestations in individuals with West Nile Virus (WNV) infection, with primary neurological involvement. By presenting a case of chorioretinal scarring secondary to WNV, we highlight the importance of a thorough ophthalmological evaluation in suspected cases of WNV to identify potential sight-threatening complications.</div></div><div><h3>Observations</h3><div>A 63-year-old woman presented with neurological symptoms following a trip to Denver, USA, including headaches, fever, and decreased consciousness. Despite initial treatment for suspected meningoencephalitis, her condition deteriorated, leading to focal seizures and profound weakness. Ophthalmological examination revealed chorioretinal lesions consistent with WNV retinopathy.</div></div><div><h3>Conclusions</h3><div>and Importance: WNV can present with neurological symptoms, and ocular complications can lead to significant visual impairment. This case report highlights the importance of asking individuals with suspected WNV about ocular symptoms. Despite the absence of a preventive treatment for ocular manifestations, clinicians must stay attentive to ocular symptoms in patients to mitigate potential complications, such as chorioretinal neovascularization, which can be treated with anti-vascular endothelial growth factor therapy injections.</div></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"38 ","pages":"Article e02095"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142432920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Immunocompromised individuals, such as those undergoing Rituximab therapy, are susceptible to severe infections by these organisms. We present a rare case of polyarticular septic arthritis caused by disseminated Ureaplasma urealyticum in a Rituximab-treated patient.
Presentation of case
A 38-year-old male with a history of schizophrenia and multiple sclerosis presented with intense pain, swelling, and fever, along with limited joint mobility. Despite initial treatment with antibiotics and surgical intervention, the patient's condition deteriorated. PCR assays confirmed the presence of Ureaplasma urealyticum, prompting a change in antibiotic therapy. With focused antimicrobial treatment and supportive care, the patient exhibited gradual improvement, although reinfection occurred one month after discharge, necessitating additional surgical interventions and antibiotic therapy.
Discussion
Septic arthritis due to Ureaplasma urealyticum is exceedingly rare but can occur in immunocompromised patients undergoing Rituximab therapy. Accurate pathogen identification using PCR assays is crucial for optimizing therapeutic outcomes in such cases. Treatment typically involves a combination of surgical debridement and tailored antimicrobial therapy with agents effective against Ureaplasma species. Close monitoring for disease recurrence and joint function is essential for long-term management.
Conclusion
This case highlights the diagnostic challenges and therapeutic complexities of septic arthritis caused by Ureaplasma urealyticum in immunocompromised patients undergoing Rituximab treatment. Interdisciplinary collaboration and the use of PCR assays for accurate pathogen identification are crucial for successful outcomes in such cases. Clinicians should consider the unique susceptibility of immunocompromised individuals to rare pathogens and tailor antimicrobial therapy accordingly.
{"title":"Disseminated Ureaplasma infection: A case report of septic polyarthritis in a patient on Rituximab therapy","authors":"Michael Axenhus , Jesper Ericson , Agata Rysinska , Annelie Petterson , Desiree Friis","doi":"10.1016/j.idcr.2024.e02101","DOIUrl":"10.1016/j.idcr.2024.e02101","url":null,"abstract":"<div><h3>Introduction</h3><div>Immunocompromised individuals, such as those undergoing Rituximab therapy, are susceptible to severe infections by these organisms. We present a rare case of polyarticular septic arthritis caused by disseminated Ureaplasma urealyticum in a Rituximab-treated patient.</div></div><div><h3>Presentation of case</h3><div>A 38-year-old male with a history of schizophrenia and multiple sclerosis presented with intense pain, swelling, and fever, along with limited joint mobility. Despite initial treatment with antibiotics and surgical intervention, the patient's condition deteriorated. PCR assays confirmed the presence of Ureaplasma urealyticum, prompting a change in antibiotic therapy. With focused antimicrobial treatment and supportive care, the patient exhibited gradual improvement, although reinfection occurred one month after discharge, necessitating additional surgical interventions and antibiotic therapy.</div></div><div><h3>Discussion</h3><div>Septic arthritis due to Ureaplasma urealyticum is exceedingly rare but can occur in immunocompromised patients undergoing Rituximab therapy. Accurate pathogen identification using PCR assays is crucial for optimizing therapeutic outcomes in such cases. Treatment typically involves a combination of surgical debridement and tailored antimicrobial therapy with agents effective against Ureaplasma species. Close monitoring for disease recurrence and joint function is essential for long-term management.</div></div><div><h3>Conclusion</h3><div>This case highlights the diagnostic challenges and therapeutic complexities of septic arthritis caused by Ureaplasma urealyticum in immunocompromised patients undergoing Rituximab treatment. Interdisciplinary collaboration and the use of PCR assays for accurate pathogen identification are crucial for successful outcomes in such cases. Clinicians should consider the unique susceptibility of immunocompromised individuals to rare pathogens and tailor antimicrobial therapy accordingly.</div></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"38 ","pages":"Article e02101"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02070
Joshua M. Garcia, Ramez I. Haddadin
Purpose
Immunizations have long been pivotal in preventing diseases like HZ (herpes zoster), caused by VZV (varicella zoster virus). This study aims to evaluate the efficacy and safety of the RZV (recombinant zoster vaccine) compared to the ZVL (zoster vaccine live) and to report rare adverse events following RZV administration.
Observation
Herein, we report an unusual case of a 59-year-old man who developed a V1-limited rash with a positive HZ PCR (polymerase chain reaction) test following administration of RZV in the United States.
Conclusion
The development of RZV has significantly improved the prevention of HZ compared to ZVL. Nevertheless, rare adverse events, such as dermatomal reactions, underscore the importance of ongoing monitoring and research into the immunomodulatory effects of RZV. Physicians should continue to administer the RZV to patients but be cognizant that reactivation may rarely subsequently occur.
Case Presentation
The patient with a history of benign prostatic hyperplasia was treated at an outside hospital two days after receiving the RZV complaining of paresthesia and a rash on his nasolacrimal area and forehead. The patient presented to the ED (emergency department), 9 days post-vaccination due to persistence of his symptoms despite use of amoxicillin, valacyclovir, and an unidentified eye drop. The dose of valacyclovir was increased, and he completed 1 g TID (three times a day) PO (per orally) for 10 days with subsequent resolution of symptoms. A positive PCR test confirmed the diagnosis of HZ. Topical mupirocin ointment was initiated and the patient was referred for ophthalmologic evaluation.
{"title":"Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review","authors":"Joshua M. Garcia, Ramez I. Haddadin","doi":"10.1016/j.idcr.2024.e02070","DOIUrl":"10.1016/j.idcr.2024.e02070","url":null,"abstract":"<div><h3>Purpose</h3><p>Immunizations have long been pivotal in preventing diseases like HZ (herpes zoster), caused by VZV (varicella zoster virus). This study aims to evaluate the efficacy and safety of the RZV (recombinant zoster vaccine) compared to the ZVL (zoster vaccine live) and to report rare adverse events following RZV administration.</p></div><div><h3>Observation</h3><p>Herein, we report an unusual case of a 59-year-old man who developed a V1-limited rash with a positive HZ PCR (polymerase chain reaction) test following administration of RZV in the United States.</p></div><div><h3>Conclusion</h3><p>The development of RZV has significantly improved the prevention of HZ compared to ZVL. Nevertheless, rare adverse events, such as dermatomal reactions, underscore the importance of ongoing monitoring and research into the immunomodulatory effects of RZV. Physicians should continue to administer the RZV to patients but be cognizant that reactivation may rarely subsequently occur.</p></div><div><h3>Case Presentation</h3><p>The patient with a history of benign prostatic hyperplasia was treated at an outside hospital two days after receiving the RZV complaining of paresthesia and a rash on his nasolacrimal area and forehead. The patient presented to the ED (emergency department), 9 days post-vaccination due to persistence of his symptoms despite use of amoxicillin, valacyclovir, and an unidentified eye drop. The dose of valacyclovir was increased, and he completed 1 g TID (three times a day) PO (per orally) for 10 days with subsequent resolution of symptoms. A positive PCR test confirmed the diagnosis of HZ. Topical mupirocin ointment was initiated and the patient was referred for ophthalmologic evaluation.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02070"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221425092400146X/pdfft?md5=c7c4850a720b4f30bcabd8eacc5847ab&pid=1-s2.0-S221425092400146X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142149645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}